Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

Canada - TSX:CHR-DB-B - CA17040TAE25

100.3 CAD
-0.1 (-0.1%)
Last: 9/17/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, CHR-DB-B scores 3 out of 10 in our fundamental rating. CHR-DB-B was compared to 9 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-B get a neutral evaluation. Nothing too spectacular is happening here. CHR-DB-B is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CHR-DB-B had positive earnings in the past year.
CHR-DB-B had a positive operating cash flow in the past year.
In multiple years CHR-DB-B reported negative net income over the last 5 years.
Each year in the past 5 years CHR-DB-B had a positive operating cash flow.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CHR-DB-B has a Return On Assets of -1.91%. This is in the lower half of the industry: CHR-DB-B underperforms 66.67% of its industry peers.
The Return On Equity of CHR-DB-B (-4.82%) is worse than 66.67% of its industry peers.
CHR-DB-B's Return On Invested Capital of 6.54% is fine compared to the rest of the industry. CHR-DB-B outperforms 77.78% of its industry peers.
CHR-DB-B had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 5.58%.
The 3 year average ROIC (5.30%) for CHR-DB-B is below the current ROIC(6.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR-DB-B has a Operating Margin (6.87%) which is in line with its industry peers.
CHR-DB-B's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 65.48%, CHR-DB-B is doing good in the industry, outperforming 77.78% of the companies in the same industry.
In the last couple of years the Gross Margin of CHR-DB-B has declined.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR-DB-B is destroying value.
The number of shares outstanding for CHR-DB-B has been reduced compared to 1 year ago.
Compared to 5 years ago, CHR-DB-B has more shares outstanding
CHR-DB-B has a better debt/assets ratio than last year.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.38 indicates that CHR-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.38, CHR-DB-B belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
The Debt to FCF ratio of CHR-DB-B is 7.89, which is on the high side as it means it would take CHR-DB-B, 7.89 years of fcf income to pay off all of its debts.
CHR-DB-B's Debt to FCF ratio of 7.89 is fine compared to the rest of the industry. CHR-DB-B outperforms 77.78% of its industry peers.
CHR-DB-B has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR-DB-B is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.54, CHR-DB-B is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 2.38
ROIC/WACC0.73
WACC8.95%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.14 indicates that CHR-DB-B should not have too much problems paying its short term obligations.
CHR-DB-B has a Current ratio (1.14) which is comparable to the rest of the industry.
CHR-DB-B has a Quick Ratio of 1.14. This is a bad value and indicates that CHR-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CHR-DB-B has a worse Quick ratio (0.61) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

CHR-DB-B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.57%, which is quite impressive.
The earnings per share for CHR-DB-B have been decreasing by -19.03% on average. This is quite bad
The Revenue for CHR-DB-B has decreased by -13.36% in the past year. This is quite bad
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

The Earnings Per Share is expected to grow by 1.21% on average over the next years.
Based on estimates for the next years, CHR-DB-B will show a decrease in Revenue. The Revenue will decrease by -5.14% on average per year.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.58, the valuation of CHR-DB-B can be described as expensive.
CHR-DB-B's Price/Earnings is on the same level as the industry average.
CHR-DB-B is valuated expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 52.04, the valuation of CHR-DB-B can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR-DB-B is on the same level as its industry peers.
CHR-DB-B is valuated expensively when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.58
Fwd PE 52.04
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than CHR-DB-B, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR-DB-B is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 53
EV/EBITDA 13.67
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR-DB-B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

More info and screens

2

5. Dividend

5.1 Amount

CHR-DB-B has a Yearly Dividend Yield of 1.60%. Purely for dividend investing, there may be better candidates out there.
CHR-DB-B's Dividend Yield is comparable with the industry average which is at 2.69.
Compared to the average S&P500 Dividend Yield of 2.38, CHR-DB-B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.6%

5.2 History

On average, the dividend of CHR-DB-B grows each year by 21.58%, which is quite nice.
CHR-DB-B does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CHR-DB-B has negative earnings and hence a negative payout ratio. The dividend may be in danger.
CHR-DB-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR-DB-B.CA Yearly Income VS Free CF VS DividendCHR-DB-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

CHORUS AVIATION INC

TSX:CHR-DB-B (9/17/2025, 7:00:00 PM)

100.3

-0.1 (-0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap2.58B
Analysts78.18
Price Target133.9 (33.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.6%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-4.66%
EPS NQ rev (3m)2.05%
EPS NY rev (1m)-4.29%
EPS NY rev (3m)1.77%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)-2.45%
Revenue NY rev (1m)-2.63%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 44.58
Fwd PE 52.04
P/S 1.89
P/FCF 53
P/OCF 30.52
P/B 4.8
P/tB 4.88
EV/EBITDA 13.67
EPS(TTM)2.25
EY2.24%
EPS(NY)1.93
Fwd EY1.92%
FCF(TTM)1.89
FCFY1.89%
OCF(TTM)3.29
OCFY3.28%
SpS53.16
BVpS20.88
TBVpS20.54
PEG (NY)0.81
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 2.38
F-Score5
WACC8.95%
ROIC/WACC0.73
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%